Actively Recruiting
Home Rehabilitation As Continuity of Care in MS
Led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Updated on 2024-11-21
20
Participants Needed
3
Research Sites
53 weeks
Total Duration
On this page
Sponsors
F
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Lead Sponsor
I
Istituto Auxologico Italiano
Collaborating Sponsor
AI-Summary
What this Trial Is About
RCT pilot study to evaluate adherence, satisfaction and feasibility in the use of a telemedicine station for balance rehabilitation in patients with multiple sclerosis. The platform is designed as a tool for maintenance rehabilitation in a home setting and not as an alternative to intensive treatment in hospital, and is therefore compared to maintenance treatment as usual (TAU) after intensive treatment.
CONDITIONS
Official Title
Home Rehabilitation As Continuity of Care in MS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Expanded Disability Status Scale score between 3 and 6
- Sensory Organisation Test Equitest values indicating balance impairment
You will not qualify if you...
- Visual impairments
- Orthopedic impairments
- Inability to perform balance rehabilitation in standing position
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
IRCCS Istituto Auxologico Italiano
Milan, MI, Italy, 20122
Actively Recruiting
2
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, MI, Italy, 20133
Not Yet Recruiting
3
IRCCS Santa Maria nascente - Fondazione Don Gnocchi
Milan, MI, Italy, 20148
Active, Not Recruiting
Research Team
P
Paolo A Confalonieri, MD
CONTACT
S
Simone Mercurio, PT
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here